You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

evolocumab

Showing 1 - 25 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rosuvastatin and Evolocumab for Coronary Artery Disease

Completed
  • Coronary Artery Disease
  • New York, New York
    Mount Sinai Hospital
Aug 2, 2023

Ischemic Stroke, Acute Trial (Evolocumab)

Not yet recruiting
  • Ischemic Stroke, Acute
  • Evolocumab
  • (no location specified)
Jan 15, 2023

Acute Metabolic Effects of Evolocumab and Atorvastatin Trial (Evolocumab)

Not yet recruiting
  • Acute Metabolic Effects of Evolocumab and Atorvastatin
  • Evolocumab
  • (no location specified)
Nov 16, 2023

Abdominal Aortic Aneurysm Trial (Evolocumab, Placebo)

Not yet recruiting
  • Abdominal Aortic Aneurysm
  • Evolocumab
  • Placebo
  • (no location specified)
Oct 12, 2023

Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis Trial in Nanjing (Evolocumab, Atorvastatin)

Not yet recruiting
  • Stroke Patients With Symptomatic Intracranial Atherosclerotic Stenosis
  • Nanjing, Jiangsu, China
    the First affiliated hospital of Nanjing Medical University
Feb 14, 2023

Acute Coronary Syndrome Trial in Baltimore (Evolocumab, Placebos)

Active, not recruiting
  • Acute Coronary Syndrome
  • Evolocumab
  • Placebos
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Dec 8, 2022

Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Percutaneous Coronary Intervention Trial in Falls Church

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Evolocumab
  • Placebo
  • Falls Church, Virginia
    Inova Fairfax Hospital
Dec 22, 2022

Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)

Recruiting
  • Malignant Glioma
  • Glioblastoma
  • Evolocumab
  • Durham, North Carolina
    Duke University Medical Center
Oct 13, 2022

Chronic Kidney Diseases, High Cholesterol Trial in Mineola, New York (Evolocumab, Placebo)

Withdrawn
  • Chronic Kidney Diseases
  • High Cholesterol
  • Evolocumab
  • Placebo
  • Mineola, New York
  • +1 more
Jul 27, 2022

Heart Failure With Reduced Ejection Fraction Trial in Badalona, Sevilla, Valencia (Evolocumab)

Completed
  • Heart Failure With Reduced Ejection Fraction
  • Evolocumab
  • Badalona, Barcelona, Spain
  • +2 more
Aug 10, 2022

Ticagrelor and Aspirin in Acute Coronary Syndrome

Recruiting
  • Acute Coronary Syndrome
  • Evolocumab
  • Harbin, Heilongjiang, China
    the first affiliated hospital of Harbin Medical University
Jun 9, 2022

Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))

Recruiting
  • Hyperlipidemias
  • Evolocumab
  • Statins (Cardiovascular Agents)
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 18, 2022

Carotid Artery Stenosis, Asymptomatic Carotid Artery Stenosis Trial in North York, Toronto (Evolocumab)

Recruiting
  • Carotid Artery Stenosis
  • Asymptomatic Carotid Artery Stenosis
  • Evolocumab
  • North York, Ontario, Canada
  • +2 more
Apr 29, 2022

PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

Not yet recruiting
  • Acute Ischemic Stroke
  • (no location specified)
Nov 14, 2023

Atherosclerotic Vascular Disease, Type2 Diabetes, Microvascular Dysfunction Trial in New York, Toronto (Placebo, Evolocumab)

Completed
  • Atherosclerotic Vascular Disease
  • +2 more
  • Placebo
  • Evolocumab
  • New York, New York
  • +1 more
Jul 11, 2022

Lung Cancer Metastatic Trial in Durham (Nivolumab, Ipilimumab, Evolocumab)

Recruiting
  • Lung Cancer Metastatic
  • Durham, North Carolina
    Duke Univ. Medical Center
May 16, 2022

Acute Coronary Syndrome Trial in Baltimore (Evolocumab, Placebo)

Active, not recruiting
  • Acute Coronary Syndrome
  • Evolocumab
  • Placebo
  • Baltimore, Maryland
    Steven Paul Schulman
Jan 19, 2022

Atherosclerotic Cardiovascular Disease Trial in Jacksonville (Evolocumab, Placebo)

Completed
Has Results
  • Atherosclerotic Cardiovascular Disease
  • Evolocumab
  • Placebo
  • Jacksonville, Florida
    University of Florida
Feb 16, 2022

Cardiovascular Disease, Myocardial Infarction, Stroke Trial (Evolocumab, Routine Lipid Management)

Recruiting
  • Cardiovascular Disease
  • +3 more
  • Evolocumab
  • Routine Lipid Management
  • Fairhope, Alabama
  • +14 more
Dec 21, 2022

Type 2 Diabetes Trial in Helsinki (Evolocumab)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Evolocumab
  • Helsinki, Finland
    Helsinki University Hospital, Biomedicum 2U
Oct 28, 2021

Clinical Trial, Acute Coronary Syndrome Trial in Seoul (Evolocumab, NIRS IVUS)

Recruiting
  • Clinical Trial
  • Acute Coronary Syndrome
  • Evolocumab
  • NIRS IVUS
  • Seoul, Korea, Republic of
    Korea University Anam Hospital
Mar 28, 2022

Homozygous Familial Hypercholesterolemia Trial in Worldwide (lerodalcibep, evolocumab)

Active, not recruiting
  • Homozygous Familial Hypercholesterolemia
  • Evanston, Illinois
  • +11 more
Jul 13, 2022

Inclisiran on Major Adverse Cardiovascular Events in French

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • Inclisiran sodium
  • +3 more
  • (no location specified)
Jul 26, 2023

Sars-CoV-2 Infection Trial in Bydgoszcz (Evolocumab, Saline solution)

Completed
  • Sars-CoV-2 Infection
  • Evolocumab
  • Saline solution
  • Bydgoszcz, Poland
    Antoni Jurasz University Hospital No. 1
Dec 14, 2022

Carotid Artery Disease Trial in Torino (Evolocumab, lipid-lowering therapy (LLT))

Recruiting
  • Carotid Artery Disease
  • Evolocumab
  • lipid-lowering therapy (LLT)
  • Torino, Piedmont, Italy
    Azienda Ospedaliera Ordine Mauriziano di Torino
Jul 22, 2021